We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Visa Growth Story to Remain Intact Despite Coronavirus Threat
Read MoreHide Full Article
Visa Inc. (V - Free Report) has announced that Coronavirus outbreak is likely to impact its cross-border e-commerce growth.
Cross-border business is likely to be negatively impacted due to reduction in cross-border travel, as people around the globe are taking precautionary measures. This has resulted in a sharp slowdown of the company’s cross-border business, particularly travel related spending in both card present and card not present.
Cross-border eCommerce unrelated to travel, however, has not been significantly impacted, except in some Asian markets. In markets where Visa processes the majority of its transactions, domestic spending growth, both credit and debit, remains largely stable with the exception of some impact in Hong Kong and Singapore
In the first quarter of fiscal 2020, cross-border volume rose 9% on a constant-dollar basis and the company processed nearly 38 billion total transactions on its network, up 11%. Visa’s cross-border volumes in the last two weeks of January were negatively impacted by the shifts in the Chinese new year with potentially some initial effects of the coronavirus outbreak.
As a result of the virus outbreak, Visa said that if cross-border business continues to show weakness through the end of the quarter, year-over-year net revenue growth in the fiscal second quarter will be approximately 2.5-3.5% lower than its previous estimate provided in the first quarter earnings conference. The company then estimated second-quarter net revenue growth to be in the low double digits, and modestly better than the first quarter (indicating revenue growth of 10% year over year).
Despite the negative news, the stock gained 5.82% in last day’s trading. Investors might are considering this outbreak as a temporary affair and that the company should do well over the long term, given an increase in personal consumption expenditure growth, shift toward electronic forms of payment and an expanding market.
In a year’s time, the stock has gained 30% compared with the industry’s rise of 28.2%.
The company’s long-term growth is 15.4% compared with the industry’s growth of 13.9%.
Another company in the same space, Mastercard Inc. (MA - Free Report) , estimates revenue growth for the first quarter of 2020 to be 9-10% year over year on constant-currency basis (200-300 basis points lower than the previous projection of year-over-year growth in low double digits). If the impact is limited to the first quarter, management believes that net revenue growth for the current year will be at the lower end of the view in low-teens at cc.
Visa carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the same space are EVO Payments, Inc. and QIWI PLC (QIWI - Free Report) . Both these stocks carry a Zacks Rank #2 (Buy). EVO Payment and QIWI surpassed estimates in the last reported quarter by 26.3% and 46.88%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Visa Growth Story to Remain Intact Despite Coronavirus Threat
Visa Inc. (V - Free Report) has announced that Coronavirus outbreak is likely to impact its cross-border e-commerce growth.
Cross-border business is likely to be negatively impacted due to reduction in cross-border travel, as people around the globe are taking precautionary measures. This has resulted in a sharp slowdown of the company’s cross-border business, particularly travel related spending in both card present and card not present.
Cross-border eCommerce unrelated to travel, however, has not been significantly impacted, except in some Asian markets. In markets where Visa processes the majority of its transactions, domestic spending growth, both credit and debit, remains largely stable with the exception of some impact in Hong Kong and Singapore
In the first quarter of fiscal 2020, cross-border volume rose 9% on a constant-dollar basis and the company processed nearly 38 billion total transactions on its network, up 11%. Visa’s cross-border volumes in the last two weeks of January were negatively impacted by the shifts in the Chinese new year with potentially some initial effects of the coronavirus outbreak.
As a result of the virus outbreak, Visa said that if cross-border business continues to show weakness through the end of the quarter, year-over-year net revenue growth in the fiscal second quarter will be approximately 2.5-3.5% lower than its previous estimate provided in the first quarter earnings conference. The company then estimated second-quarter net revenue growth to be in the low double digits, and modestly better than the first quarter (indicating revenue growth of 10% year over year).
Despite the negative news, the stock gained 5.82% in last day’s trading. Investors might are considering this outbreak as a temporary affair and that the company should do well over the long term, given an increase in personal consumption expenditure growth, shift toward electronic forms of payment and an expanding market.
In a year’s time, the stock has gained 30% compared with the industry’s rise of 28.2%.
The company’s long-term growth is 15.4% compared with the industry’s growth of 13.9%.
Another company in the same space, Mastercard Inc. (MA - Free Report) , estimates revenue growth for the first quarter of 2020 to be 9-10% year over year on constant-currency basis (200-300 basis points lower than the previous projection of year-over-year growth in low double digits). If the impact is limited to the first quarter, management believes that net revenue growth for the current year will be at the lower end of the view in low-teens at cc.
Visa carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the same space are EVO Payments, Inc. and QIWI PLC (QIWI - Free Report) . Both these stocks carry a Zacks Rank #2 (Buy). EVO Payment and QIWI surpassed estimates in the last reported quarter by 26.3% and 46.88%, respectively.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>